000597.SZ
000597.SZ
CNE0000009G0
NEP.
Loading chart...

Company Profile

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals manufacturing, pharmaceutical distribution, pharmaceutical engineering, biopharmaceuticals, and other businesses in China. It offers vitamin products, such as vitamin C, vitamin B1, vitamin B6, and L-carnitine series; anti- infective products, such as fosfomycin series, azithromycin series, amantadine series, polyalkali hydrochloride, chloramphenicol, and other products; and reproductive system and hormone products comprising carboprost suppositories, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets. It also provides nervous system products, such as piracetam series, levetiracetam series, vinpocetine, and other products; narcotics and psychotropic drugs and related products, including morphine hydrochloride injections and tablets, oxycodone hydrochloride injection, compound glycyrrhiza series, and acetaminophen-codeine tablets; anti-AIDS products comprising Krughar /zidovudine tablets and capsules, efavirenz tablets, and other products; and in vitro biological diagnostic reagent products for HIV, HBV, HCV, HPV, and TB. In addition, it offers general health products, including glucosamine sulfate chondroitin collagen D3 calcium capsules, protein powder, probiotic powder, effervescent tablets, chewable tablets, solid drinks, and other products. Further, it provides Enterogermina, magnesium aluminum carbonate chewable tablets; compound proglutamine-cimetidine tablets; acetaminophen tablets; pain relievers, phenacetin, pregabalin, noscapine syrup, and citrate table; and other products, as well as cell therapy products. Additionally, it engages in medical distribution business. The company was founded in 1946 and is based in Shenyang, China.

Related stocks

688276.SS
688276.SS • China
CHANGCHUN BCHT BIOTECHNOLOGY CO
17.79 CNY
1.1B USD 1Y -19.6%
600252.SS
600252.SS • China
GUANGXI WUZHOU ZHONGHENG GROUP
2.25 CNY
1.07B USD 1Y -17.6%
002275.SZ
002275.SZ • China
GLSJ
12.35 CNY
1.09B USD 1Y -16%
000566.SZ
000566.SZ • China
HAINAN HAIYAO
4.71 CNY
914.35M USD 1Y -13.7%
002390.SZ
002390.SZ • China
XINBANG PHAR.
3.01 CNY
875.5M USD 1Y -19.5%
002349.SZ
002349.SZ • China
JINGHUA PHARM
9.24 CNY
1.15B USD 1Y +28.3%
600488.SS
600488.SS • China
TIANJIN TIANYAO PHARMACEUTICAL
6.47 CNY
1.06B USD 1Y +59%
000915.SZ
000915.SZ • China
WIT DYNE
24.22 CNY
849.25M USD 1Y -23.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.2% p.a.
Max Drawdown (5Y)
-57.4%
Sharpe Ratio (5Y)
-0.12
Beta Factor
0.07
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -57.4% in the extended horizon.
ende